Clinical Trial Update: Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation

View source ↗

Summary

This clinical trial update examines Graves' disease potentially triggered by Epstein-Barr Virus lytic reactivation, with the study status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Snippet

Sponsor: Xiao-Ming Mao | Conditions: Graves Disease, Graves' Disease in Remission | Status: NOT_YET_RECRUITING